Ngapas, Acmad N.
HRN: 28-10-22 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2025
CEFTRIAXONE 1G (VIAL)
11/12/2025
11/18/2025
IV
2 Grams
OD
Cap Lr
Waiting Final Action
11/24/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/24/2025
12/08/2025
IV
4.5g
Q6hr
CAP-HR
Checking Initial Appropriateness
12/06/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/06/2025
12/12/2025
IVTT
2.25 G
Q6
Cap HR
Checking Final Appropriateness